CCL26 and liver cancer: The high expression of FARSB may constitute an immunosuppressive microenvironment by affecting the expression levels of relevant chemokines, CCL26 and CX3CL1, and helping the infiltration of Th2 cells, resulting in a poor prognosis for liver cancer patients.